Propel testing excellence with Mayo Clinic quality
Mayo Clinic Laboratories is a one-stop laboratory solution, offering commercial laboratories a vast testing menu, unparalleled customer service, and optimized processes. We work collaboratively with partners to assess their needs, providing the testing they need to expand into new areas and meet their business goals.
As the reference lab for Mayo Clinic, we’ve developed robust logistics and testing protocols applied uniformly for all specimens received, no matter their geographic origin. Whether you send us one test order or thousands, each sample receives the same treatment and level of care, ensuring superior results that help our partners better serve their clients.
“Our clients want personal experiences. They want someone to answer the phone. They want someone to provide answers when they're looking for results of a sample sent a couple days ago. and we deliver those answers.”
Angie Reese-Davis, director of operations, logistics, and specimen services, Mayo Clinic Laboratories

Our difference
News and updates
The latest
Mayo Clinic Laboratories is transforming diagnostics with innovations in 2025 that turned research into real-world solutions for better patient care.
As part of Mayo Clinic’s Neuro-Oncology practice, the Division of Laboratory Genetics and Genomics tests about 50 brain tumors a week, and upwards of 1,500 brain tumors a year from all over the world.
Topic highlights include: Biden administration releases doses of flu medicine from national stockpile and pediatric medicine makers say they are running 24/7 to meet increased demand
Matthew Binnicker, Ph.D., director of the Clinical Virology Laboratory at Mayo Clinic, joins host Bobbi Pritt, M.D., on this week’s episode of the "Answers From the Lab" podcast. In this episode, they discuss the ongoing respiratory virus season, a new test for measles available at Mayo Clinic Laboratories, and some tips to stay healthy.
This week's research roundup features: Neuropathological findings in COVID-19: an autopsy cohort
As a result of winter weather across the U.S. and the upcoming holiday this weekend, we are experiencing logistical challenges, which may result in testing delays or cancelations.
Topic highlights include: New members-only health clinic to start seeing Rochester patients in January, A staffing expert shows how telehealth is stepping in to fill the staffing shortage, Congress reaches major health policy deal on Medicare, Medicaid, and pandemic preparedness
Blood diversion as a mechanism to lower blood culture contamination rates.
William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, joins “Answers From the Lab” for his weekly leadership update with host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic. In this episode, Drs. Pritt and Morice share their predictions for the new year and discuss why they believe 2023 will be a pivotal year for health care.
Due to the Christmas and New Year's holiday's (recognized on Sunday, December 25th, and Sunday, January 1st ), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and turnaround times are not affected, plan ahead.
Terra Lasho is an assistant professor of medicine and principal research technologist for the Division of Hematology, where she works to help transform patient care from bench to bedside.
Effective Jan. 2, U.S. Customs and Border Protection will enhance the enforcement of the Centers for Disease Control and Prevention (CDC) requirements on the importation of biological specimens. Please include the CDC permit within your shipment. Failure to comply will result in your shipment being denied admissibility by U.S. Customs and Border Protection. If an entry is denied, the carrier is required to return or destroy the shipment.
This week's research roundup features: Expanding the platelet inventory to mitigate the impact of severe shortages